Case Challenge

Treatment of Breast Cancer in a 64-Year-Old Black Female With Multiple Positive Lymph Nodes

Source: Adjuvant HER2-Positive Cancer: Integrating Prognostic Tools and Clinical Advances to Optimize Treatment

Treatment of Breast Cancer in a 64-Year-Old Black Female With Multiple Positive Lymph Nodes


Faculty:

  • Linda T. Vahdat, MD

CME CREDIT INFORMATION

Release Date: 12/06/07

Expiration Date: 12/05/08


Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss clinical trial updates of adjuvant treatment of HER2-positive breast cancer
  • Explain the use of aromatase inhibitors vs tamoxifen in patients with hormone receptor–positive breast cancer
  • Describe cardiotoxicity concerns in the treatment of breast cancer

Test your ability to make optimal treatment decisions using patient histories and diagnostic information and see the case unfold according to your choices. Compare your answers with your peers and our expert faculty’s recommendations, and then review the supporting data.
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Educational grant provided by:

Educational grants support only the CME-certified components of this program.